Recent advances in cellular signaling interplay between redox metabolism and autophagy modulation in cancer: An overview of molecular mechanisms and …

MA Rahman, KR Ahmed, F Haque, MN Park, B Kim - Antioxidants, 2023 - mdpi.com
Autophagy is a fundamental homeostatic process in which certain cellular components are
ingested by double-membrane autophagosomes and then degraded to create energy or to …

Targeting NAD+ Metabolism: Preclinical Insights into Potential Cancer Therapy Strategies

AN Mogol, AZ Kaminsky, DJ Dutton… - …, 2024 - academic.oup.com
NAD+ is one of the most important metabolites for cellular activities, and its biosynthesis
mainly occurs through the salvage pathway using the nicotinamide phosphoribosyl …

Targeting ribosome biogenesis reinforces ERK-dependent senescence in pancreatic cancer

MC Rowell, X Deschênes-Simard, S Lopes-Paciencia… - Cell Cycle, 2023 - Taylor & Francis
Pancreatic adenocarcinomas (PDAC) often possess mutations in K-Ras that stimulate the
ERK pathway. Aberrantly high ERK activation triggers oncogene-induced senescence …

[HTML][HTML] Targeting Triple NK Cell Suppression Mechanisms: A Comprehensive Review of Biomarkers in Pancreatic Cancer Therapy

S Fanijavadi, M Thomassen, LH Jensen - International Journal of …, 2025 - mdpi.com
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer with poor outcomes due
to frequent recurrence, metastasis, and resistance to treatment. A major contributor to this …

Inhibitors of NAD+ Production in Cancer Treatment: State of the Art and Perspectives

MS Ghanem, I Caffa, F Monacelli… - International Journal of …, 2024 - mdpi.com
The addiction of tumors to elevated nicotinamide adenine dinucleotide (NAD+) levels is a
hallmark of cancer metabolism. Obstructing NAD+ biosynthesis in tumors is a new and …

[HTML][HTML] Gaining Insight into Mitochondrial Targeting: AUTAC-Biguanide as an Anticancer Agent

J Vatté, V Bourdeau, G Ferbeyre, AR Schmitzer - Molecules, 2024 - mdpi.com
AUTAC-Biguanide is a hybrid compound designed to target mitochondria, inducing their
degradation by mitophagy. This study unveils the potential of biguanides as cancer cell …

[HTML][HTML] Metabolic signatures in pancreatic ductal adenocarcinoma: diagnostic and therapeutic implications

R Gong, Y Hu, Q Yu, L Fang, H Ren - Journal of Pancreatology, 2023 - journals.lww.com
Pancreatic ductal adenocarcinoma (PDAC) is the prototypical aggressive cancer that
develops in nutrient-deficient and hypoxic microenvironment. PDAC overcomes these …

[HTML][HTML] Differential Mitochondrial Redox Responses to the Inhibition of NAD+ Salvage Pathway of Triple Negative Breast Cancer Cells

J Kollmar, J Xu, D Gonzalves, JA Baur, LZ Li, J Tchou… - Cancers, 2024 - mdpi.com
Abstract Background/Objectives: Cancer cells rely on metabolic reprogramming that is
supported by altered mitochondrial redox status and an increased demand for NAD+. Over …

Knowledge map** of metformin use on cancers: a bibliometric analysis (2013–2023)

C Pan, Y Wei, J Dai, L Yang, Z Ding… - Frontiers in …, 2024 - frontiersin.org
There is substantial evidence from clinical and preclinical studies suggesting an association
between metformin use and a reduced risk of cancer. However, the effects of metformin use …

Bidirectional relationship between pancreatic cancer and diabetes mellitus: a comprehensive literature review

S Sapoor, M Nageh, NM Shalma, R Sharaf… - Annals of Medicine …, 2024 - journals.lww.com
Pancreatic cancer (PC) is a fatal malignant disease. It is well known that the relationship
between PC and type 2 diabetes mellitus (T2DM) is a complicated bidirectional relationship …